인바이츠바이오코아(주)

{
  "address": "서울특별시 금천구",
  "ceo_name": "신승수,양성우",
  "certificate": [
    {
      "cert_number": "031135021100656",
      "changes": "",
      "disclosure_date": "2003-05-19",
      "first_cert_date": "2003-05-19",
      "no": "1",
      "type": "연구개발기업",
      "valid_period": "2003-05-19 ~ 2005-05-18"
    },
    {
      "cert_number": "051135021201068",
      "changes": "",
      "disclosure_date": "2005-05-19",
      "first_cert_date": "2003-05-19",
      "no": "2",
      "type": "연구개발기업",
      "valid_period": "2005-05-19 ~ 2007-05-18"
    },
    {
      "cert_number": "20070102267",
      "changes": "",
      "disclosure_date": "2007-06-29",
      "first_cert_date": "2003-05-19",
      "no": "3",
      "type": "연구개발유형",
      "valid_period": "2007-05-19 ~ 2009-05-18"
    },
    {
      "cert_number": "20120108191",
      "changes": "",
      "disclosure_date": "2012-10-10",
      "first_cert_date": "2003-05-19",
      "no": "4",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2012-10-10 ~ 2014-10-09"
    },
    {
      "cert_number": "20140111488",
      "changes": "",
      "disclosure_date": "2014-10-24",
      "first_cert_date": "2003-05-19",
      "no": "5",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2014-10-10 ~ 2016-10-09"
    },
    {
      "cert_number": "20160300454",
      "changes": "",
      "disclosure_date": "2016-09-29",
      "first_cert_date": "2003-05-19",
      "no": "6",
      "type": "벤처투자유형",
      "valid_period": "2016-10-10 ~ 2018-10-09"
    },
    {
      "cert_number": "20180300685",
      "changes": "",
      "disclosure_date": "2018-10-11",
      "first_cert_date": "2003-05-19",
      "no": "7",
      "type": "벤처투자유형",
      "valid_period": "2018-10-10 ~ 2020-10-09"
    },
    {
      "cert_number": "20200301231",
      "changes": "",
      "disclosure_date": "2020-10-22",
      "first_cert_date": "2003-05-19",
      "no": "8",
      "type": "벤처투자유형",
      "valid_period": "2020-10-10 ~ 2022-10-09"
    },
    {
      "cert_number": "20221026010036",
      "changes": "",
      "disclosure_date": "2022-10-26",
      "first_cert_date": "2003-05-19",
      "no": "9",
      "type": "벤처투자유형",
      "valid_period": "2022-10-10 ~ 2025-10-09"
    },
    {
      "cert_number": "20251028010014",
      "changes": "",
      "disclosure_date": "2025-10-28",
      "first_cert_date": "2003-05-19",
      "no": "10",
      "type": "벤처투자유형",
      "valid_period": "2025-10-10 ~ 2028-10-09"
    }
  ],
  "company_name": "인바이츠바이오코아(주)",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 16933362000,
      "cost_of_sales": 15054639000,
      "current_assets": 49004276000,
      "current_liabilities": 35014663000,
      "gross_profit": 10285374000,
      "net_income": -1134740000,
      "net_income_bs": -1279555000,
      "non_current_assets": 33769950000,
      "non_current_liabilities": 639144000,
      "non_operating_expenses": 9659983000,
      "non_operating_income": 4351510000,
      "operating_profit": 4173733000,
      "revenue": 25340013000,
      "sga_expenses": 6111641000,
      "total_assets": 82774226000,
      "total_equity": 47120419000,
      "total_liabilities": 35653807000
    },
    "2023": {
      "capital_stock": 18042667000,
      "cost_of_sales": 16923145000,
      "current_assets": 37767988000,
      "current_liabilities": 44892176000,
      "gross_profit": 5096749000,
      "net_income": -4876279000,
      "net_income_bs": -4226518000,
      "non_current_assets": 51785619000,
      "non_current_liabilities": 1339920000,
      "non_operating_expenses": 5670618000,
      "non_operating_income": 4224370000,
      "operating_profit": -3430031000,
      "revenue": 22019894000,
      "sga_expenses": 8526780000,
      "total_assets": 89553607000,
      "total_equity": 43321511000,
      "total_liabilities": 46232096000
    },
    "2024": {
      "capital_stock": 19249430000,
      "cost_of_sales": 17129979000,
      "current_assets": 35174784000,
      "current_liabilities": 45274782000,
      "gross_profit": 4515730000,
      "net_income": 1695830000,
      "net_income_bs": 1003685000,
      "non_current_assets": 58000379000,
      "non_current_liabilities": 2184935000,
      "non_operating_expenses": 4385532000,
      "non_operating_income": 5632200000,
      "operating_profit": 449162000,
      "revenue": 21645709000,
      "sga_expenses": 4066568000,
      "total_assets": 93175163000,
      "total_equity": 45715446000,
      "total_liabilities": 47459717000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "13,516,000,000",
      "changes": "13,516,000,000",
      "date": "2021-03-31"
    },
    {
      "amount": "20,277,000,000",
      "changes": "20,277,000,000",
      "date": "2021-03-31"
    },
    {
      "amount": "6,758,628,161",
      "changes": "6,758,628,161",
      "date": "2021-02-26"
    },
    {
      "amount": "10,137,923,580",
      "changes": "10,137,923,580",
      "date": "2021-02-26"
    },
    {
      "amount": "4,999,995,000",
      "changes": "4,999,995,000",
      "date": "2015-03-27"
    }
  ],
  "main_products": "PK/PD분석, 생동/임상CRO, 유전자분석",
  "phone": "02-2027-****",
  "years": [
    2024,
    2023,
    2022
  ]
}